ADVISORY RESEARCH INC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q1 2021$686,000
-35.0%
7,248
-16.4%
0.05%
-37.7%
Q4 2020$1,056,000
+11.5%
8,666
-20.0%
0.08%
-16.3%
Q3 2020$947,000
-14.5%
10,839
-36.8%
0.09%
-7.1%
Q2 2020$1,108,000
+86.5%
17,147
+29.0%
0.10%
+141.5%
Q1 2020$594,000
-51.8%
13,294
-32.8%
0.04%
-28.1%
Q4 2019$1,232,000
+211.9%
19,771
+88.3%
0.06%
+200.0%
Q3 2019$395,00010,4980.02%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders